Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF

Healthcare Biotechnology


GREY:MDCGF - Post by User

Medicago Inc > Meidcago is well positioned for a strong g
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by cornpieon Feb 23, 2012 1:46pm
160 Views
Post# 19574577

RE: RE: Meidcago is well positioned for a strong g

RE: RE: Meidcago is well positioned for a strong g

Yes MDG is like watching paint dry, still holding and waiting!

One of my other favourites and also one of Technical Buy with smaller float and market cap is CFR. Their 100% owned sub signed a great distrubution deal last week and released more news today, trading at .12 right now with a ton of upside potential, possibly even more than MDG.

Avivagen Announces U.S. Distribution Agreement
2/16/2012 7:30:00 AM - nw

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities